Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Femasys Inc. Common Stock
FEMY | US
0.37
USD-0.01
-1.75%
FEMY | US
Loading StockChartView...
About Femasys Inc. Common Stock
Sector
Healthcare
Industry
Medical Instruments & Supplies
Earnings date
30/06/2024
As of date
02/06/2026
Close
0.37
Open
0.38
High
0.38
Low
0.36
Femasys Inc. a biomedical company develops novel solutions for women's healthcare market in the United States and internationally. The company provides FemVue saline-air device a contrast-generating product in the United States Canada Japan and Hong Kong; FemCath a cornual balloon catheter a single intrauterine directional delivery product that allows for selective evaluation of an individual fallopian tube; and FemCerv a biopsy device for endocervical curettage which can be used to sample cervical cells and tissue circumferentially with sample containment within the device to minimize contamination. It also develops permanent birth control solutions such as FemBloc and FemChec; FemaSeed an artificial insemination solution; and FemEMB a product candidate for endometrial sampling in support of uterine cancer detection testing. In addition the company provides non-surgical product technologies. It offers its infertility products to obstetrics-gynecological physicians related healthcare professionals women's healthcare provider organizations and reproductive endocrinologists. Femasys Inc. was incorporated in 2004 and is headquartered in Suwanee Georgia.
View LessFEMY | US
Risk
133.7
Sharpe
-0.49
Luna's Score
30/100
Recommendation
Sell
Luna says (FEMY | US)
What's Working
Value Stock (Price to Book < 3)
What's not Working
Negative Momentum (Declining Price)
Price Below SMA10D
High Short-term Volatility
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Low negative Beta, possible Low Liquidity (< -0.4)
Weak Operating Margin (< 10%)
Declining Revenue (< 0%)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
Loading RiskMeterView...
10 days
169.8%1 month
133.7%3 months
102.0%6 months
93.7%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
2.41
Debt to equity
0.63
Debt to assets
0.35
Ent. to EBITDA
0.24
Ent. to rev.
21.75
PEG
-
Other Fundamentals
EBITDA
-16.12M
MarketCap
8.26M
MarketCap(USD)
8.26M
Div. yield
-
Op. margin
-2.02K
Erngs. growth
-
Rev. growth
-30.90
Ret. on equity
-138.37
Short ratio
5.72
Short perc.
3.74
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
0.20
Range1M
0.20
Range3M
0.30
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
0.31
Price X volume
232.95K
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 0.24 | 4.19 | Cheaper |
| Ent. to Revenue | 21.75 | 8.10 | Expensive |
| PE Ratio | - | 47.18 | - |
| Price to Book | 2.41 | 5.71 | Cheaper |
| Dividend Yield | - | 1.35 | - |
| Std. Deviation (3M) | 102.02 | 56.96 | Riskier |
| Debt to Equity | 0.63 | 0.92 | Cheaper |
| Debt to Assets | 0.35 | 0.27 | Expensive |
| Market Cap | 8.26M | 10.37B | Emerging |
